Incidence of Cervical Squamous Intraepithelial Lesions Associated With HIV Serostatus, CD4 Cell Counts, and Human Papillomavirus Test Results

Authors:
  • RBRobert D. Burk
    Robert D. Burk
  • JPJoel M. Palefsky
    Joel M. Palefsky
  • LML. Stewart Massad
    L. Stewart Massad
  • JBJi Yon Bang
    Ji Yon Bang
  • KAKathryn Anastos
    Kathryn Anastos
  • HMHoward Minkoff
    Howard Minkoff
  • MBMelanie C. Bacon
    Melanie C. Bacon
  • ALAlexandra M. Levine
    Alexandra M. Levine
  • DWD. Heather Watts
    D. Heather Watts
  • MSMichael J. Silverberg
    Michael J. Silverberg

Abstract
Cervical cancer screening recommendations in the United States have been recently updated and now advise using an interval of 3 years between screenings in healthy women 30 years or older who have normal cytology results and who test negative for oncogenic (cancer-associated) human papillomavirus (HPV) DNA.1,2 The recommended interval is 6 to 12 months for women with normal cytology results and detectable oncogenic HPV. If no HPV test is conducted, 3 consecutive normal annual Papanicolaou (Pap) smear results are required before the Pap smear frequency is changed to once every 2 or 3 years. Support for these recommendations comes from several large observational studies.1-5

This publication has 11 references indexed in Scilit: